Expanding options for HER2 advanced breast cancer: Taking trial data to the clinic

Expanding options for HER2 advanced breast cancer: Taking trial data to the clinic

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment ArsenalПодробнее

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer

2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment ApproachesПодробнее

2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment Approaches

Optimizing Therapy in HER2+ Disease with Dr. Reshma MahtaniПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani

What's New and on the Horizon for Metastatic Breast Cancer?Подробнее

What's New and on the Horizon for Metastatic Breast Cancer?

HER2 In Breast Cancer: Testing Guidelines and New Treatment ApproachesПодробнее

HER2 In Breast Cancer: Testing Guidelines and New Treatment Approaches